LEG vs. ABT
LEG (Leggett & Platt, Incorporated) and ABT (Abbott Laboratories) are both stocks. LEG operates in Furnishings, Fixtures & Appliances (Consumer Cyclical), while ABT operates in Medical Devices (Healthcare). Over the past 10 years, LEG returned -12.01%/yr vs 10.97%/yr for ABT. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
LEG vs. ABT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LEG achieves a -10.05% return, which is significantly higher than ABT's -14.07% return. Over the past 10 years, LEG has underperformed ABT with an annualized return of -12.01%, while ABT has yielded a comparatively higher 10.97% annualized return.
LEG
- 1D
- -2.20%
- 1M
- -16.02%
- 6M
- -15.21%
- YTD
- -10.05%
- 1Y
- 4.60%
- 3Y*
- -29.16%
- 5Y*
- -24.27%
- 10Y*
- -12.01%
- ALL TIME*
- 6.33%
ABT
- 1D
- 0.09%
- 1M
- 15.48%
- 6M
- -1.99%
- YTD
- -14.07%
- 1Y
- -14.30%
- 3Y*
- 0.59%
- 5Y*
- -0.75%
- 10Y*
- 10.97%
- ALL TIME*
- 12.78%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.15B | $1.25B | $1.20B | |
| $18.50M | $23.27M | $28.03M |
LEG vs. ABT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LEG Leggett & Platt, Incorporated | -10.05% | 17.02% | -61.93% | -13.45% | -17.78% | -3.76% | -9.05% | 47.13% | -22.25% | 0.58% |
ABT Abbott Laboratories | -14.07% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
Correlation
The correlation between LEG and ABT is 0.24, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.24 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.28 |
Correlation (All Time) Calculated using the full available price history since Nov 5, 1987 | 0.25 |
Fundamentals
LEG:
$1.34B
ABT:
$184.11B
LEG:
$1.60
ABT:
$3.11
LEG:
6.13
ABT:
34.03
LEG:
0.45
ABT:
3.96
LEG:
1.33
ABT:
2.82
LEG:
$3.03B
ABT:
$46.59B
LEG:
$717.40M
ABT:
$26.46B
LEG:
$433.10M
ABT:
$9.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LEG vs. ABT — Risk / Return Rank
LEG
ABT
LEG vs. ABT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Leggett & Platt, Incorporated (LEG) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LEG | ABT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.64 | ||
| Sortino ratioReturn per unit of downside risk | +1.18 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 0.92 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | -0.37 | +0.53 |
| Martin ratioReturn relative to average drawdown | 0.34 | -0.71 | +1.05 |
Loading charts...
Drawdowns
LEG vs. ABT - Drawdown Comparison
The maximum LEG drawdown since its inception was -86.41%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for LEG and ABT.
Loading charts...
Drawdown Indicators
| LEG | ABT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.41% | -45.66% | -40.75% |
Max Drawdown (1Y)Largest decline over 1 year | -28.51% | -38.61% | +10.10% |
Max Drawdown (3Y)Largest decline over 3 years | -76.68% | -39.64% | -37.04% |
Max Drawdown (5Y)Largest decline over 5 years | -84.29% | -39.64% | -44.65% |
Max Drawdown (10Y)Largest decline over 10 years | -86.41% | -39.64% | -46.77% |
Current DrawdownCurrent decline from peak | -79.20% | -22.17% | -57.03% |
Average DrawdownAverage peak-to-trough decline | -19.84% | -10.90% | -8.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.72% | 20.16% | -6.44% |
Volatility
LEG vs. ABT - Volatility Comparison
The current volatility for Leggett & Platt, Incorporated (LEG) is 11.32%, while Abbott Laboratories (ABT) has a volatility of 12.65%. This indicates that LEG experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LEG | ABT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.32% | 12.65% | -1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 32.38% | 21.13% | +11.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.36% | 26.55% | +22.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.74% | 22.89% | +19.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.96% | 23.95% | +16.01% |
Dividends
LEG vs. ABT - Dividend Comparison
LEG's dividend yield for the trailing twelve months is around 2.04%, less than ABT's 2.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.35% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
LEG Leggett & Platt, Incorporated | 2.04% | 1.82% | 6.35% | 6.95% | 5.40% | 4.03% | 3.61% | 3.11% | 4.19% | 2.98% | 2.74% | 3.00% |
Financials
LEG vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Leggett & Platt, Incorporated and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LEG and ABT have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABT has higher volatility (12.65%) compared to LEG (11.32%). In terms of maximum drawdown, LEG dropped -86.41% vs ABT's -45.66%.
LEG currently has the higher Sharpe Ratio (0.09 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LEG and ABT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer